,0
0,Earnings Preview: AbbVie (ABBV) Q3 Earnings Expected to Decline
1,Earnings Preview: United States Steel (X) Q3 Earnings Expected to DeclineZacks
2,Earnings Preview: Principal Financial (PFG) Q3 Earnings Expected to DeclineZacks
3,"The Zacks Analyst Blog Highlights Visa, AbbVie, BHP Group, Caterpillar and Boston Scientific"
4,"Top Research Reports for Visa, AbbVie & BHP"
5,Allergan Aesthetics Supports Breast Cancer Patients and Celebrates Breast Reconstruction Patients Through The Reblossom Project
6,Is AbbVie Stock Too Pricey to Touch Right Now?
7,AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
8,Investors Heavily Search Hubbell Inc (HUBB): Here is What You Need to KnowZacks
9,Is Trending Stock NIO Inc. (NIO) a Buy Now?Zacks
10,Johnson & Johnson Was Saved By Its Focus On MedTech And Innovative Medicine
11,3 Supercharged Dividend Stocks to Buy if There's a Stock Market Sell-Off
12,AbbVie's RINVOQ® (upadacitinib) Receives Health Canada Approval as the First and Only Oral Therapy for the Treatment of Adults with Moderately to Severely Active Crohn's Disease
13,AbbVie's EPKINLY™ (epcoritamab injection/epcoritamab for injection) Receives Health Canada Authorization with Conditions as the First and Only Subcutaneous Bispecific Antibody to Treat Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
